Diabetes affects many people in the world, type 1 diabetes being a condition that can affect anyone, causing them to be on ...

In previous treat-to-target trials, adjustments to the dose of basal insulin have been made at least weekly, according to ...

Houston’s Axiom Space launched its fourth human spaceflight mission on Wednesday. One of the mission’s experiments hopes to ...

Eli Lillys Mounjaro KwikPen gains approval in India, targeting diabetes and obesity with its dual-action formula for weight ...

While many systems already pair continuous glucose monitors (CGMs) and insulin pumps, PharmaSens and SiBionics may have ...

VX-880 stem cell therapy led to 92% reduction in insulin use, with 10 out of 12 patients eliminating injections entirely in a ...

Discover how the Axiom-4 mission to the ISS is revolutionizing diabetes treatment with groundbreaking research on glucose ...

Explore how real-world evidence and biosimilars enhance insulin access and adherence, improving diabetes care and outcomes ...

Axiom-4 astronauts are set to study insulin behaviour in microgravity, potentially transforming diabetes treatment and aiding ...

The market is driven by rising diabetes prevalence worldwide and increasing adoption of wearable and connected devices ...

During their 14-day stay aboard the orbital lab, some astronauts on the Axiom-4 mission will be wearing continuous glucose ...